Literature DB >> 7955036

p53 mutations in lung cancers from Japanese mustard gas workers.

Y Takeshima1, K Inai, W P Bennett, R A Metcalf, J A Welsh, S Yonehara, Y Hayashi, M Fujihara, M Yamakido, M Akiyama.   

Abstract

Mustard gas (MG) is a mutagenic and carcinogenic alkylating agent, and is a known risk factor for occupational lung cancer. Our hypothesis is that lung cancers from MG workers contain mutations (G:C to A:T transitions) as the result of MG-produced DNA promutagenic adducts in the p53 tumor suppressor gene. We analyzed 12 primary lung cancers from Japanese MG factory workers and 12 lung cancers from non-exposed individuals. Genomic DNA was isolated from archival paraffin-embedded tissues. Exons 5-8 were amplified by polymerase chain reaction using p53-specific primers, and sequenced by dideoxy termination methods. Six out of 12 lung cancers from MG workers contained a total of eight somatic point mutations: two cases had double G:C to A:T transitions; one had a G:C to T:A transversion; one case had an A:T to G:C transition; and two cases had single base deletions. Four of the six mutated purines occurred on the non-transcribed, DNA-coding strand. Out of 12 unexposed cases, there were six single base mutations in six cancers, and no double mutations. The p53 mutational frequency in the MG-exposed cases is similar to the non-exposed controls and the usual smoking-related lung cancers reported previously. However, the distinctive double mutations (G:C to A:T transition) observed in two cases are unusual and may be related to MG exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955036     DOI: 10.1093/carcin/15.10.2075

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Bronchial leiomyoma in a chemical warfare victim-a causative agent or an incidental finding: A case report.

Authors:  Samad Behesthirouy; Farzad Kakaei; Ramin Azhough; Ashraf Fakhrjou
Journal:  Int J Surg Case Rep       Date:  2012-05-14

2.  Mustard gas exposure and carcinogenesis of lung.

Authors:  Alireza Hosseini-khalili; David D Haines; Ehsan Modirian; Mohammadreza Soroush; Shahriar Khateri; Rashmi Joshi; Kazem Zendehdel; Mostafa Ghanei; Charles Giardina
Journal:  Mutat Res       Date:  2009-06-24       Impact factor: 2.433

3.  Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans.

Authors:  M Balali-Mood; Sh Mousavi; B Balali-Mood
Journal:  Emerg Health Threats J       Date:  2008-11-07

4.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

5.  P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

Authors:  T Lasky; E Silbergeld
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

6.  Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS.

Authors:  M Yamakido; S Ishioka; K Hiyama; A Maeda
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

7.  Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients.

Authors:  Rashid Mir; Mirza Masroor; Jamsheed Javid; Imtiyaz Ahamad; Shazia Farooq; Prasant Yadav; Mariyam Zuberi; Maqbool Lone; P C Ray; Alpana Saxena
Journal:  South Asian J Cancer       Date:  2016 Jan-Mar

8.  Sulfur Mustard Exposure from Dredged Artillery Shell in a Commercial Clammer.

Authors:  Jenna Otter; Alveena Dawood; Joseph D'Orazio
Journal:  Clin Pract Cases Emerg Med       Date:  2017-09-29

9.  p16/CDKN2 gene and p53 gene alterations in Japanese non-smoking female lung adenocarcinoma.

Authors:  Y Takeshima; T Nishisaka; R Kawano; K Kishizuchi; S Fujii; S Kitaguchi; K Inai
Journal:  Jpn J Cancer Res       Date:  1996-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.